Cited by 252Drug Transport and Resistance MechanismsBarrier Structure and Function StudiesPharmacogenetics and Drug Metabolism

The DOI matches its Crossref record; 214 of the 215 references it cites were found in a registry or an index.

Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders

Open access

Qosa, Hisham, Miller, David S., Pasinelli, Piera, Trotti, Davide·2015·Brain Research

DOI 10.1016/j.brainres.2015.07.005PMC PMC4681613

Open this paper in CoChat — free account

Abstract

The strength of the blood-brain barrier (BBB) in providing protection to the central nervous system from exposure to circulating chemicals is maintained by tight junctions between endothelial cells and by a broad range of transporter proteins that regulate exchange between CNS and blood. The most important transporters that restrict the permeability of large number of toxins as well as therapeutic agents are the ABC transporters. Among them, P-gp, BCRP, MRP1 and MRP2 are the utmost studied. These efflux transporters are neuroprotective, limiting the brain entry of neurotoxins; however, they could also restrict the entry of many therapeutics and contribute to CNS pharmacoresistance. Characterization of several regulatory pathways that govern expression and activity of ABC efflux transporters in the endothelium of brain capillaries have led to an emerging consensus that these processes are complex and contain several cellular and molecular elements. Alterations in ABC efflux transporters expression and/or activity occur in several neurological diseases. Here, we review the signaling pathways that regulate expression and transport activity of P-gp, BCRP, MRP1 and MRP2 as well as how their expression/activity changes in neurological diseases. This article is part of a Special Issue entitled SI: Neuroprotection.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.brainres.2015.07.005

Cites

214 of 214 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Diagnostic and Statistical Manual of Mental Disorders(DSM)
Leong, F. T. L. (2008) · Sage eBooks · doi:10.4135/9781412963978.n182 · Cited by 10,861
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
Parkinson's disease
Kalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595
Structure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185
Pathobiology of ischaemic stroke: an integrated view
Dirnagl, U., Iadecola, C., & Moskowitz, M. A. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01401-0 · Cited by 3,943
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280
The blood-brain barrier/neurovascular unit in health and disease
Hawkins, B. T., & Davis, T. P. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.4 · Cited by 2,661
The blood–brain barrier: an overview
Ballabh, P., Braun, A., & Nedergaard, M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.016 · Cited by 2,276

Flagged first, then by citations

Show all 215 references

1 of the 215 references couldn’t be matched to a known paper.

Sorted by citations

Items 101–200 of 252

Self-Emulsifying Drug–Delivery Systems Modulate P-Glycoprotein Activity: Role of Excipients and Formulation Aspects
AboulFotouh, K., Allam, A., El‐Badry, M., & El‐Sayed, A. M. (2018) · Nanomedicine · doi:10.2217/nnm-2017-0354 · Cited by 25
Small Molecule PET Tracers for Transporter Imaging
Kilbourn, M. R. (2017) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2017.05.005 · Cited by 24
Surface engineered liposomal delivery of therapeutics across the blood brain barrier: recent advances, challenges and opportunities
Ghosh, S., Lalani, R., Patel, V., Bhowmick, S., & Misra, A. R. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1676721 · Cited by 25
Actin filament‐associated protein 1 (AFAP‐1) is a key mediator in inflammatory signaling‐induced rapid attenuation of intrinsic P‐gp function in human brain capillary endothelial cells
Hoshi, Y., Uchida, Y., Tachikawa, M., Ohtsuki, S., & Terasaki, T. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13960 · Cited by 23
Recent Approaches and Success of Liposome-Based Nano Drug Carriers for the Treatment of Brain Tumor
Shaw, T. K., & Paul, P. (2021) · Current Drug Delivery · doi:10.2174/1567201818666211213102308 · Cited by 24
Development and Validation of an In-Cell Western for Quantifying P-Glycoprotein Expression in Human Brain Microvascular Endothelial (hCMEC/D3) Cells
McInerney, M. P., Pan, Y., Short, J. L., & Nicolazzo, J. A. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2016.12.017 · Cited by 22
Paracellular tightness and the functional expression of efflux transporters P-gp and BCRP in bEnd3 cells
Yang, S., Jin, H. W., & Zhao, Z. (2018) · Neurological Research · doi:10.1080/01616412.2018.1460701 · Cited by 22
Endothelial dysfunction in neurodegenerative disease: Is endothelial inflammation an overlooked druggable target?
Ritson, M., Wheeler-Jones, C. P. D., & Stolp, H. B. (2024) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2024.578363 · Cited by 23
5‑Phenyl-1,3,4-oxadiazol-2(3 H )‑ones Are Potent Inhibitors of Notum Carboxylesterase Activity Identified by the Optimization of a Crystallographic Fragment Screening Hit
Mahy, W., Willis, N. J., Zhao, Y., Woodward, H. L., Svensson, F., Sipthorp, J., Vecchia, L., Ruza, R. R., Hillier, J., Kjær, S., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01391 · Cited by 22
Activation of melatonin receptor (MT1/2) promotes P-gp transporter in methamphetamine-induced toxicity on primary rat brain microvascular endothelial cells
Jumnongprakhon, P., Sivasinprasasn, S., Govitrapong, P., Tocharus, C., & Tocharus, J. (2017) · Toxicology in Vitro · doi:10.1016/j.tiv.2017.02.010 · Cited by 22
Contributions of Drug Transporters to Blood-Brain Barriers
Liu, L., & Liu, X. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-7647-4_9 · Cited by 21
Genetic Predictors of Antipsychotic Efflux Impairment via Blood-Brain Barrier: Role of Transport Proteins
Nasyrova, R. F., Shnayder, N. A., Osipova, S. M., Khasanova, A. K., Efremov, I. S., Al-Zamil, M., Петрова, М. М., Narodova, E. A., Garganeeva, N. P., & Shipulin, G. A. (2023) · Genes · doi:10.3390/genes14051085 · Cited by 21
Blood-brain barrier dysfunction in hepatic encephalopathy: pathophysiology, diagnostic assessment and therapeutic perspectives
Guennec, L. L., Mouri, S., Thabut, D., & Weiss, N. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01645-3 · Cited by 19
Response to Sodium Channel blocking Antiseizure medications and coding polymorphisms of Sodium Channel genes in Taiwanese epilepsy patients
Lin, C., Ho, C.-J., Lu, Y., & Tsai, M. (2021) · BMC Neurology · doi:10.1186/s12883-021-02395-2 · Cited by 19
Virtual Screening Directly Identifies New Fragment-Sized Inhibitors of Carboxylesterase Notum with Nanomolar Activity
Steadman, D., Atkinson, B. N., Zhao, Y., Willis, N. J., Frew, S., Monaghan, A. E., Patel, C., Armstrong, E., Costelloe, K., Magno, L., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01735 · Cited by 19
Implication of ABC transporters in non-proliferative diseases
Grigoreva, T. A., Sagaidak, A. V., Novikova, D., & Tribulovich, V. G. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175327 · Cited by 18
Intranasal administration of sertraline ensures sustained brain delivery and antidepressant effect in a mouse model of depression
Silva, S., Fonseca, C., Bicker, J., Falcão, A. C., & Fortuna, A. C. (2023) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2023.12.002 · Cited by 20
ABC Transporters in Extrahepatic Tissues: Pharmacological Regulation in Heart and Intestine
Villanueva, S. S. M., Zhang, W., Zecchinati, F., Mottino, A. D., & Vore, M. E. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180327092639 · Cited by 19
Impact of Zn 2+ on ABC Transporter Function in Intact Isolated Rat Brain Microvessels, Human Brain Capillary Endothelial Cells, and in Rat in Vivo
Zaremba, A., Helm, F., & Fricker, G. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00987 · Cited by 19
How Soluble Fms-Like Tyrosine Kinase 1 Could Contribute to Blood-Brain Barrier Dysfunction in Preeclampsia?
Torres‐Vergara, P., Rivera, R., & Escudero, C. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2021.805082 · Cited by 17
Functional Expression of Multidrug-Resistance (MDR) Transporters in Developing Human Fetal Brain Endothelial Cells
Lye, P., Bloise, E., Império, G. E., Chitayat, D. A., & Matthews, S. G. (2022) · Cells · doi:10.3390/cells11142259 · Cited by 18
Involvement of phase II enzymes and efflux transporters in the metabolism and absorption of naringin, hesperidin and their aglycones in rats
Guo, X., Cao, X., Fang, X., Guo, A., & Li, E. (2022) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2021.2012562 · Cited by 17
Polymorphisms in potential mercury transporter ABCC2 and neurotoxic symptoms in populations exposed to mercury vapor from goldmining
Kolbinger, V., Engström, K., Berger, U., & Böse‐O’Reilly, S. (2019) · Environmental Research · doi:10.1016/j.envres.2019.05.043 · Cited by 17
Pharmacodynamic mechanisms of anti-inflammatory drugs on the chemosensitization of multidrug-resistant cancers and the pharmacogenetics effectiveness
Dehkordi, N. G., Mirzaei, S. A., & Elahian, F. (2020) · Inflammopharmacology · doi:10.1007/s10787-020-00765-9 · Cited by 17
Effects of bacterial and viral pathogen-associated molecular patterns (PAMPs) on multidrug resistance (MDR) transporters in brain endothelial cells of the developing human blood–brain barrier
Lye, P., Bloise, E., & Matthews, S. G. (2023) · Fluids and Barriers of the CNS · doi:10.1186/s12987-023-00409-4 · Cited by 17
3D-QSAR AND CONTOUR MAP ANALYSIS OF TARIQUIDAR ANALOGUES AS MULTIDRUG RESISTANCE PROTEIN-1 (MRP1) INHIBITORS.
Kakarla, P., Inupakutika, M. A., Devireddy, A. R., Gunda, S. K., Willmon, T. M., Ranjana, K. C., Shrestha, U., Ranaweera, I., Hernandez, A. J., Barr, S. R., et al. (2016) · International Journal of Pharmaceutical Sciences and Research · doi:10.13040/ijpsr.0975-8232.7(2).554-72 · Cited by 17
Impacts of Drug Interactions on Pharmacokinetics and the Brain Transporters: A Recent Review of Natural Compound-Drug Interactions in Brain Disorders
Khadka, B., Lee, J., Park, E. K., Kim, K.-T., & Bae, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041809 · Cited by 16
Association of symptom severity and cerebrospinal fluid alterations in recent onset psychosis in schizophrenia-spectrum disorders – An individual patient data meta-analysis
Campana, M., Yakimov, V., Moussiopoulou, J., Maurus, I., Löhrs, L., Raabe, F. J., Jäger, I. M., Mortazavi, M., Benros, M. E., Jeppesen, R., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.04.011 · Cited by 14
Advancements in Using Polymeric Nanoparticles for Blood–Brain Barrier Penetration in Neurological Disorders
Wu, Y., Moonshi, S. S., & Ta, H. T. (2025) · ACS Applied Bio Materials · doi:10.1021/acsabm.4c01956 · Cited by 20
NMR Metabolomics for Stem Cell type discrimination
Castiglione, F., Ferro, M., Mavroudakis, E., Pellitteri, R., Bossolasco, P., Zaccheo, D., Morbidelli, M., Silani, V., Mele, A., Moscatelli, D., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-16043-8 · Cited by 16
Enhanced P-glycoprotein expression under high-altitude hypoxia contributes to increased phenytoin levels and reduced clearance in rats
Zhang, J., Zhang, M., Zhang, J., & Wang, R. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105490 · Cited by 16
A systematic review and meta-analysis of the association of ABCC2/ABCG2 polymorphisms with antiepileptic drug responses in epileptic patients
Zan, X., Yue, G., Hao, Y., & Sima, X. (2021) · Epilepsy Research · doi:10.1016/j.eplepsyres.2021.106678 · Cited by 16
Pro-inflammatory and anti-inflammatory compounds exert similar effects on P-glycoprotein in blood–brain barrier endothelial cells
Torres‐Vergara, P., & Penny, J. I. (2018) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12893 · Cited by 16
Pharmacokinetics of pericyte involvement in small-molecular drug transport across the blood-brain barrier
Mihajlica, N., Betsholtz, C., & Hammarlund‐Udenaes, M. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.06.018 · Cited by 18
Liposomes against Alzheimer’s Disease: Current Research and Future Prospects
Constantinou, C., Meliou, K., Σκούρας, Α., Siafaka, P. I., & Christodoulou, P. (2024) · Biomedicines · doi:10.3390/biomedicines12071519 · Cited by 18
Cubosomes: evolving platform for intranasal drug delivery of neurotherapeutics
Gawarkar‐Patil, P., Mahajan, B., Pawar, A., & Dhapte-Pawar, V. S. (2024) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-024-00665-7 · Cited by 19
In Vivo Induction of P-Glycoprotein Function can be Measured with [18F]MC225 and PET
García-Varela, L., Rodríguez-Pérez, M., Custodia, A., Moraga‐Amaro, R., Colabufo, N. A., Aguiar, P., Sobrino, T., Dierckx, R., van Waarde, A., Elsinga, P. H., et al. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00302 · Cited by 16
Regulation of P-glycoprotein by miR-27a-3p at the Brain Endothelial Barrier
Hammad, S., Mabondzo, A. M., Hamoudi, R., & Harati, R. (2021) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2021.10.021 · Cited by 15
Glymphatic system and intracerebral hemorrhage: Identifying molecular targets for future therapeutic advancements
Mukherjee, U., Chowdhury, S., Nagada, K. K., Hasan, M. M., Ghosh, B., Joshi, A., Datta, A., Roy, J., & Bhattacharya, P. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102900 · Cited by 17
Treatment and protective effects of metalloproteinase inhibitors alone and in combination with N-Acetyl cysteine plus vitamin E in rats exposed to aflatoxin B1
Traş, B., Faki, H. E., Kutahya, Z. O., Bahçıvan, E., Dik, B., Bozkurt, B., & Üney, K. (2021) · Toxicon · doi:10.1016/j.toxicon.2021.02.012 · Cited by 14
Pregnane X Receptor Not Nuclear Factor-kappa B Up-regulates P-glycoprotein Expression in the Brain of Chronic Epileptic Rats Induced by Kainic Acid
Yu, N., Zhang, Y., Zhang, K., Cheng, Y.-F., Ma, H., & Di, Q. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2224-x · Cited by 14
Drug Transport at the Brain and Endothelial Dysfunction in Preeclampsia: Implications and Perspectives
Torres‐Vergara, P., Escudero, C., & Penny, J. I. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01502 · Cited by 14
Hydrogen alleviated cognitive impairment and blood‒brain barrier damage in sepsis-associated encephalopathy by regulating ABC efflux transporters in a PPARα-dependent manner
Bai, Y., Mi, W., Meng, X., Dong, B., Jiang, Y., Lu, Y., & Yu, Y. (2023) · BMC Neuroscience · doi:10.1186/s12868-023-00795-3 · Cited by 14
L-type amino acid transporter 1 (LAT1)-utilizing efflux transporter inhibitors can improve the brain uptake and apoptosis-inducing effects of vinblastine in cancer cells
Montaser, A. B., Markowicz-Piasecka, M., Sikora, J., Jalkanen, A. J., & Huttunen, K. M. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119585 · Cited by 13
The Route of Nanomaterials Entering Brain
Liu, Y., & He, Q. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-804598-5.00002-7 · Cited by 14
Blood‑brain barrier dysfunction in schizophrenia: Mechanisms and implications (Review)
Lv, S., & Luo, C. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5594 · Cited by 18
Transporter-mediated drug–drug interactions – Study design, data analysis, and implications for in vitro evaluations
Fu, S., Yu, F., Sun, T., & Hu, Z. (2021) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2021.100096 · Cited by 12
Modeling the Blood–Brain Barrier to Understand Drug Delivery in Alzheimer’s Disease
Wasielewska, J. M., Chaves, J., White, A. R., & Oikari, L. E. (2020) · Exon Publications eBooks · doi:10.36255/exonpublications.alzheimersdisease.2020.ch7 · Cited by 13
Increasing Intracellular Levels of Iron with Ferric Ammonium Citrate Leads to Reduced P-glycoprotein Expression in Human Immortalised Brain Microvascular Endothelial Cells
Newman, S. A., Pan, Y., Short, J. L., & Nicolazzo, J. A. (2021) · Pharmaceutical Research · doi:10.1007/s11095-021-03006-y · Cited by 13
Prenylated quinolinecarboxylic acid derivative prevents neuronal cell death through inhibition of MKK4
Ogura, M., Kikuchi, H., Shakespear, N., Suzuki, T., Yamaki, J., Homma, Y., Oshima, Y., & Homma, Y. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.10.008 · Cited by 12
The Function and Expression of ATP-Binding Cassette Transporters Proteins in the Alzheimer's Disease
Aykaç, A., & Sehirli, A. Ö. (2021) · Global Medical Genetics · doi:10.1055/s-0041-1735541 · Cited by 12
A Map of Transcriptomic Signatures of Different Brain Areas in Alzheimer’s Disease
Ferrari, R. R., Fantini, V., Garofalo, M., Di Gerlando, R., Dragoni, F., Rizzo, B., Spina, E., Rossi, M., Calatozzolo, C., Profka, X., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011117 · Cited by 14
Overcoming biological barriers: Precision engineered extracellular vesicles for personalized neuromedicine
Ravichandiran, V., Kesharwani, A., Anupriya, Bhaskaran, M., Parihar, V. K., Bakhshi, S., Velayutham, R., & Kumarasamy, M. (2024) · Precision medicine and engineering. · doi:10.1016/j.preme.2024.100010 · Cited by 11
Drug resistance in glioblastoma: from chemo- to immunotherapy
Sharma, S., Chepurna, O. M., & Sun, T. (2023) · Cancer Drug Resistance · doi:10.20517/cdr.2023.82 · Cited by 11
Neurovascular dysfunction in psychiatric disorders: Underlying mechanisms and therapeutic approaches
Sanches, E. S., Simões, D. M., Baptista, F. I., & Silva, A. P. (2024) · European Journal of Clinical Investigation · doi:10.1111/eci.14319 · Cited by 10
Alzheimer's disease brain endothelial-like cells reveal differential drug transporter expression and modulation by potentially therapeutic focused ultrasound
Chaves, J. C. S., Wasielewska, J. M., Cuní‐López, C., Rantanen, L. M., Lee, S., Koıstınaho, J., White, A. R., & Oikari, L. E. (2023) · Neurotherapeutics · doi:10.1016/j.neurot.2023.10.009 · Cited by 10
The expected characteristics of an in vitro human Blood Brain Barrier model derived from cell lines, for studying how ABC transporters influence drug permeability
Puech, C., Delavenne, X., & Perek, N. (2018) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2018.03.002 · Cited by 9
A high throughput blood–brain barrier model incorporating shear stress with improved predictive power for drug discovery
Chavarria, D., Abbaspour, A. R., Celestino, N., Shah, N., Sankar, S., & Baker, A. B. (2023) · Biomicrofluidics · doi:10.1063/5.0150887 · Cited by 10
Membrane transporters in traumatic brain injury: Pathological, pharmacotherapeutic, and developmental implications
Hagos, F. T., Adams, S. M., Poloyac, S. M., Kochanek, P. M., Horvat, C. M., Clark, R. S. B., & Empey, P. E. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.02.011 · Cited by 9
Inhibition of Fatty Acid Synthesis Aggravates Brain Injury, Reduces Blood-Brain Barrier Integrity and Impairs Neurological Recovery in a Murine Stroke Model
Janssen, L., Ai, X., Zheng, X., Wei, W., Çağlayan, A. B., Kılıç, E., Wang, Y., Hermann, D. M., Venkataramani, V., Bähr, M., et al. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.733973 · Cited by 9
P-glycoprotein Expression Is Upregulated in a Pre-Clinical Model of Traumatic Brain Injury
Vita, S. M., Redell, J. B., Maynard, M. E., Zhao, J., Grill, R. J., Dash, P. K., & Grayson, B. E. (2020) · Neurotrauma Reports · doi:10.1089/neur.2020.0034 · Cited by 9
Review of pharmacogenetics of antiseizure medications: focusing on genetic variants of mechanistic targets
Lin, C., Ho, C.-J., Chen, S., Lu, Y., & Tsai, M. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1411487 · Cited by 9
The 3D Brain Unit Network Model to Study Spatial Brain Drug Exposure under Healthy and Pathological Conditions
Vendel, E., Rottschäfer, V., & de Lange, E. C. M. (2020) · Pharmaceutical Research · doi:10.1007/s11095-020-2760-y · Cited by 8
Modeling the Blood-Brain Barrier Using Human-Induced Pluripotent Stem Cells
Mesentier-Louro, L. A., Suhy, N., Broekaart, D. W. M., Bula, M., Pereira, A. C., & Blanchard, J. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3287-1_11 · Cited by 8
Functional relevance of the multi-drug transporter abcg2 on teriflunomide therapy in an animal model of multiple sclerosis
Schrewe, L., Guse, K., Tietz, S., Remlinger, J., Demir, S., Pedreiturria, X., Hoepner, R., Salmen, A., Pistor, M., Turner, T. J., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1677-z · Cited by 8
Single-Nucleotide Polymorphisms as Biomarkers of Antipsychotic-Induced Akathisia: Systematic Review
Nasyrova, R. F., Vaiman, E. E., Repkina, V. V., Khasanova, A. K., Asadullin, A. R., Shipulin, G. A., Altynbekov, K. S., Al-Zamil, M., Петрова, М. М., & Shnayder, N. A. (2023) · Genes · doi:10.3390/genes14030616 · Cited by 8
PET Imaging of ABC Transporters at the Blood-Brain Barrier
García-Varela, L., Mossel, P., Benadiba, M., Savolainen, H., Colabufo, N. A., Windhorst, A. D., Elsinga, P. H., van Waarde, A., & Luurtsema, G. (2020) · Springer eBooks · doi:10.1007/978-3-030-53176-8_22 · Cited by 8
Nanodelivery of antiretroviral drugs to nervous tissues
Lawal, S. K., Olojede, S. O., Faborode, O. S., Aladeyelu, O. S., Matshipi, M. N., Sulaiman, S. O., Naidu, E. C., Rennie, C. O., & Azu, O. O. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1025160 · Cited by 7
Regulation of the ATP‐binding cassette transporters ABCB1, ABCG2 and ABCC5 by nuclear receptors in porcine blood–brain barrier endothelial cells
Ho, Y. S., Torres‐Vergara, P., & Penny, J. I. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16196 · Cited by 7
Benzyl [11C]Hippurate as an Agent for Measuring the Activities of Organic Anion Transporter 3 in the Brain and Multidrug Resistance-Associated Protein 4 in the Heart of Mice
Kikuchi, T., Okamura, T., Okada, M., Ogawa, M., Suzuki, C., Wakizaka, H., Yui, J., Fukumura, T., Gee, A. D., & Zhang, M.-R. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00454 · Cited by 7
Repression of adenosine triphosphate–binding cassette transporter ABCG2 by estrogen increases intracellular glutathione in brain endothelial cells following ischemic reperfusion injury
Shin, J. A., Jeong, S. I., Kim, H. W., Jang, G., Ryu, D., Ahn, Y., Choi, J. H., Choi, Y., & Park, E. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.02.020 · Cited by 7
Investigation on P-Glycoprotein Function and Its Interacting Proteins under Simulated Microgravity
Li, Y., Huang, L., Iqbal, J., & Deng, Y. (2021) · Space Science & Technology · doi:10.34133/2021/9835728 · Cited by 7
Designing a Small Molecule for PET Radiotracing: [18F]MC225 in Human Trials for Early Diagnosis in CNS Pathologies
Mastropasqua, F., Luurtsema, G., Filosa, C., & Colabufo, N. A. (2025) · Molecules · doi:10.3390/molecules30183696 · Cited by 6
Breast Cancer Brain Metastasis: Bridging Biological Mechanisms to Therapeutic Innovations
Feng, J. Q., Tao, Y., Li, F., & Liu, S. (2025) · MedComm – Oncology · doi:10.1002/mog2.70043 · Cited by 6
The Role of Pharmacogenetic Testing in Optimizing Antipsychotic Therapy
Otmakhov, A., Proydina, D. S., Kibirova, A. Y., Kidyaeva, A. V., & Nasyrova, R. F. (2024) · Personalized Psychiatry and Neurology · doi:10.52667/2712-9179-2024-4-4-34-42 · Cited by 6
Use of PET Imaging to Assess the Efficacy of Thiethylperazine to Stimulate Cerebral MRP1 Transport Activity in Wild-Type and APP/PS1-21 Mice
Wölfl‐Duchek, M., Mairinger, S., Hernández-Lozano, I., Filip, T., Zoufal, V., Löbsch, M., Stanek, J., Kuntner, C., Wanek, T., Bauer, M., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126514 · Cited by 6
Possible New Histological Prognostic Index for Large B-Cell Lymphoma
Nitta, H., Takizawa, H., Mitsumori, T., Iizuka, H., Araki, Y., Fujishiro, M., Tomita, S., Kishikawa, S., Hashizume, A., Sawada, T., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12196324 · Cited by 5
Improved chemical synthesis, identification and evaluation of prospective centrally active oxime antidotes for the treatment of nerve agent exposure
Valdez, C. A., Lam, D., Lao, V., Subramanian, A., Enright, H. A., Malfatti, M. A., Be, N. A., & Dreyer, M. L. (2023) · Tetrahedron · doi:10.1016/j.tet.2023.133598 · Cited by 5
Nutritional Modulation of Impaired Blood-Brain Barrier Integrity and Function in Major Depression
Adžić, M., Lukić, I., Mitić, M., Zerajic, E. F., Glavonic, E., Jovanović, M., & Ivković, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146917 · Cited by 6
The Effects of P‐glycoprotein Modulators on the Transition of Levofloxacin to Rat Brain, Testicle, and Plasma: In Vivo and In Silico Studies
Çetin, G., Traş, B., & Üney, K. (2021) · ChemistrySelect · doi:10.1002/slct.202102122 · Cited by 5
DRUG TRANSPORT IN THE BRAIN
Sangha, V., Williams, E. I., Ronaldson, P. T., & Bendayan, R. (2022) · Wiley eBooks · doi:10.1002/9781119739883.ch14 · Cited by 5
In vitro models of microbiota-gut-brain axis communication at the blood-brain-barrier interface
Davies, M. R., Cross, C., Aburto, M. R., Cryan, J. F., & Wardill, H. R. (2026) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x261419964 · Cited by 4
Nose-to-Brain delivery of genistein-loaded peppermint lipid nanocapsules for neuroprotection against Alzheimer’s Disease: Formulation, Characterization, pharmacokinetic and Pharmacodynamic studies
Labib, M. S., Abd-Allah, H., Bazan, L. S., Ibrahim, H. M., & Abdel-Mottaleb, M. M. A. (2026) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2026.115066 · Cited by 4
Report on the Myomatrix Conference April 22–24, 2012, University of Nevada, Reno, Nevada, USA
Rutkowski, A., Bönnemann, C. G., Brown, S., Þorsteinsdóttir, S., Dominov, J. A., Rüegg, M. A., Matter, M. L., Guttridge, D. C., Crosbie, R. H., Kardon, G., et al. (2012) · Neuromuscular Disorders · doi:10.1016/j.nmd.2012.06.353 · Cited by 4
Impact of reduced P‐glycoprotein function on digoxin concentrations in patients with dementia
Ali, I., Guidone, D., Nicolazzo, J. A., & Brouwer, K. L. R. (2019) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14049 · Cited by 4
The Role of Glutathione in Viral Diseases of the Central Nervous System
Lima, J. E. (2018) · InTech eBooks · doi:10.5772/intechopen.76579 · Cited by 4
Efflux pump inhibition to enhance brain targeting delivery
Chen, R., Zhao, X. G., & Hu, K. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814001-7.00008-1 · Cited by 4
Nano-carriers for brain disorders targeting the blood brain barrier (BBB) crossing strategies
Gupta, K. R., Dabhekar, S., Dixit, M., & Umekar, M. J. (2021) · Indian Journal of Pharmacy and Pharmacology · doi:10.18231/j.ijpp.2020.035 · Cited by 4
Straightforward method for singularized and region-specific CNS microvessels isolation
Dayton, J. R., Franke, M. C., Yuan, Y., & Cruz‐Orengo, L. (2019) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2019.02.007 · Cited by 3
The Blood–Brain Barrier in Diabetes Mellitus
Gray, S. M., & Barrett, E. J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809454-9.00011-1 · Cited by 3
Alzheimer’s disease brain endothelial-like cells reveal differential drug transporter expression and modulation by potentially therapeutic focused ultrasoundPreprint
Chaves, J. C. S., Wasielewska, J. M., Cuní‐López, C., Rantanen, L. M., Lee, S., Koıstınaho, J., White, A. R., & Oikari, L. E. (2023) · Research Square · doi:10.21203/rs.3.rs-2605800/v1 · Cited by 3
Transcranial Focal Electric Stimulation Avoids P-Glycoprotein Over-Expression during Electrical Amygdala Kindling and Delays Epileptogenesis in Rats
Fonseca‐Barriendos, D., Castañeda‐Cabral, J. L., Martínez-Cuevas, F. L., Besio, W. G., Valdés‐Cruz, A., & Rocha, L. (2023) · Life · doi:10.3390/life13061294 · Cited by 2
Ferric Ammonium Citrate Reduces Claudin-5 Abundance and Function in Primary Mouse Brain Endothelial Cells
Runwal, P., Pyun, J., Newman, S. A., Mawal, C., Bush, A. I., Koehn, L. M., & Nicolazzo, J. A. (2025) · Pharmaceutical Research · doi:10.1007/s11095-025-03826-2 · Cited by 2
Engineering silica nanoparticle-based drug delivery systems for glioblastoma therapy
Munasir, M., Maulana, S. A., Nurlaili, R. A., Taufiq, A., Faaizatunnisa, N., Ariesta, M. N., Suaebah, E., Putri, N. P., Sunaryono, Astuti, S. D., et al. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108178 · Cited by 4
Membrane Transporters and Pharmacological Implications
Cucullo, L., & Liles, T. (2016) · Journal of Pharmacovigilance · doi:10.4172/2329-6887.1000e155 · Cited by 2
Improved synthesis of 6-bromo-7-[11C]methylpurine for clinical use
Okamura, T., Kikuchi, T., Ogawa, M., & Zhang, M. (2024) · EJNMMI Radiopharmacy and Chemistry · doi:10.1186/s41181-024-00240-8 · Cited by 2
Barriers of the CNS and Their Contribution to Drug-Resistant Epilepsy
Díaz-Coránguez, M., Auzmendi, J., Fuentes-Mejía, M., Cosme, T. M., Lazarowski, A., & Rocha, L. (2024) · AAPS introductions in the pharmaceutical sciences · doi:10.1007/978-3-031-62604-3_8 · Cited by 2
Biochemical risk factors associated with refractory epilepsy: alpha synuclein and adenosine deaminase
Şener, N., Keti, D. B., Güleç, A., Canpolat, M., Per, H., Gümüş, H., & Muhtaroğlu, S. (2024) · Revista română de medicină de laborator · doi:10.2478/rrlm-2024-0021 · Cited by 2
Liposomes in drug targeting to brain tumors
Dahiya, S., & Dahiya, R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90773-6.00006-3 · Cited by 2
Structure of the Blood Brain Barrier and the Role of Transporters in the movement of substrates across the barriersPreprint
Singh, A., & Vellapandian, C. (2022) · Qeios · doi:10.32388/5giw6a · Cited by 2

Authors: Qosa, H., Miller, D. S., Pasinelli, P., & Trotti, D.
Affiliations: Thomas Jefferson University (US)
National Institutes of Health (US)
Corresponding author: Qosa, Hisham
Trotti, Davide
ORCID: Qosa, Hisham
Pasinelli, Piera
Trotti, Davide
Venue: Brain Research
Publisher: Elsevier BV
Published: 2015-12
Volume: 1628
Issue: Pt B
Pages: 298-316
ISSN: 0006-8993 (ISSN-L)
DOI: 10.1016/j.brainres.2015.07.005
PMC: PMC4681613
OpenAlex: W908901015
Cited by: 249
References: 215
Citations by year: 2026: 17 · 2025: 15 · 2024: 19 · 2023: 27 · 2022: 26 · 2021: 30 · 2020: 27 · 2019: 23 · 2018: 22 · 2017: 18 · 2016: 23 · 2015: 1
FWCI: 2.29
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Brain Research (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute of Health (RO1-NS074886)
Intramural Research program NIH/NIEHS
Topics: Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
Keywords: ABC transporters, blood-brain barrier, P-glycoprotein, ABCG2, MRP1, MRP2, efflux pumps, transporter regulation, tight junctions, neurological disorders, neuroprotection, signaling pathways, brain capillary endothelium
MeSH terms: Animals, Blood-Brain Barrier, Humans, Nervous System Diseases, ATP-Binding Cassette Transporters

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks